Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
National Pharmaceutical Council’s CER Daily Newsfeed for January 31, 2023, featured 2 articles published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The articles were “Canadian Study Shows Greater Alignment Between Clinical Benefit, Cancer Drug Prices,” and “COTA Joins Multistakeholder Clinical Research Data Sharing Alliance.”
Kaiser Permanente spotlighted a study published in the January 2023 issue of AJMC®, titled “Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care Utilization.” The study indicated that telephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns. The study was also cited by mHealthIntelligence.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More